ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Resistance to First-line Osimertinib in EGFR-mutant NSCLC: Tissue is the Issue.

Zofia Piotrowska et al.PubMed ↗Publisher ↗

No numbers read from the abstract.